Analysis of plasma citrulline and intestinal morphometry in mice with hepatosplenic schistosomiasis

Surgical Infections

Volumn 11, Issue 5, 2010, Pages 419-426

  Siqueira, Luciana T ^a   Ferraz, Álvaro Antônio B ^a   Campos, Josemberg M ^a   De Lima, José Luiz ^b   Albuquerque, Mônica C P A ^b   De Lima Aires, André ^b   Ribeiro, Maria Helena M Lima ^b   Cavalcanti, Maria Taciana H ^b   De Lima B Cavalcanti, Carmelita ^b   Ferraz, Edmundo MacHado ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Keizo Asami Immunopathology Laboratory   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATOSPLENIC SCHISTOSOMIASIS; INTESTINE CELL; INTESTINE MUCOSA; INTESTINE VILLUS; LIVER DISEASE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; SPLEEN DISEASE; SPLENECTOMY;

ANIMALS; BODY WEIGHT; CITRULLINE; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; INTESTINAL MUCOSA; JEJUNUM; LIVER DISEASES; MICE; MICROSCOPY; PLASMA; SCHISTOSOMIASIS; SPLENECTOMY; SPLENIC DISEASES;

EID: 77957601137     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.066     Document Type: Article

References (64)

1. Organización Mundial de la Salud. Prevención y controle de la esquistosomiasis y las geohelmintiasis: Informe de un comité de expertos de la OMS. Serie de informes técnicos 912, Ginebra, Suiza. 2005.
2. Brasilian Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Vigilância e controle de moluscos de importância epidemiológica: Diretrizes técnicas: Programa de Vigilância e Controle da Esquistossomose (PCE)/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Second edition. Brasília. Editora do Ministério da Saúde. 2008.
3. Ferreira ILM, Silva TPT. Mortalidade por esquistossomose no Brasil: 1980-2003. Rev Patol Trop 2007;36:67-74.
4. Coura JR, Amaral RS. Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas. Mem Inst Oswaldo Cruz [periódico na Internet] 99 13-19. 2004 Ago. Available at http://scielo.br/scielo. Accessed January 22, 2009.
5. Brandt CT, Leite CRC, Manhães-de-Castro FM, et al. Nitric oxide monocyte production levels in patients with the hepatosplenic form of Schistosoma mansoni infection who underwent splenectomy, ligature of the left gastric vein and auto implantation of spleen tissue in the major omentum. Acta Cirur Bras 2006;21:285-289.
6. Bina JC, Prata A. Esquistossomose na área hiperendêmica de Taquarendi: Infecção pelo Schistosoma mansoni e formas graves. Rev Soc Bras Trop 2003;36:211-216.
7. Domingues ALC Ultrassonografia na Esquistossomose hepatoesplênica: Avaliação da intensidade da fibrose periportal e da hipertensão porta [doctoral thesis]. Recife. Universidade Federal de Pernambuco. 1998.
8. Ferraz AAB, Lopes EPA, Araújo JGC, et al. Varizes de fundo gástrico na hipertensão portal esquistossomótica: Resultados cirúrgicos. Rev Col Bras Cir 2003;30:21-28.
9. El-Rooby A, Gad-el-Mawla N, Galil N, et al. Studies on the malabsorption syndrome among egyphtians malabsorptions in bilharzial hepatic fibrosis. J Egypt Med Assoc 1963;46:777-782.
10. Enquist IF, Golding MR, Aiello RG, et al. The effect of portal hypertension on intestinal absorption. Surg Gynecol Obstet 1965;120:87-91.
11. Pucci H, Vilela MP, Miszputen SJ, et al. Estudo da absorção intestinal das gorduras na Esquistossomose mansônica humana. Rev Ass Med Brasil 1978;24:341-344.
12. Coutinho EM, Ferreira HS, Assunção ML, et al. The use of protein hydrolysate improves the protein intestinal absorption in undernourished mice infected with Schistosoma mansoni. Rev Soc Bras Med Trop 2002;35:585-590.
13. Machado RJC, Amorim AG, Lira V, et al. Análise morfométrica do intestino delgado de esquistossomóticos. An Fac Med Fed Pernamb 1996;41:34-42.
14. Nigro SP, Miszputen SJ, Hayashi H, Saad FA. Estudo morfométrico da mucosa jejunal na Esquistossomose mansônica humana. Rev Ass Med Brasil 1984;30:61-63.
15. Penna FJ, Brasileiro Filho G. Lack of correlation between jejunal mucosal morphology and intestinal absorption in the hepatoesplenic form of Schistosomiasis mansoni. Arq Gastroenterol 1988;25:224-228.
16. Mott CB, Neves DP, Bettarello A. Absorção intestinal na forma hepatoesplênica da Esquistossomose mansônica. Rev Hosp Clin Fac Med São Paulo 1971;26:55-60.
17. Windmueller H, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol 1981;241: E473-E480.
18. Hoogenraad N, Totino N, Elmer H, et al. Inhibition of intestinal citrulline synthesis causes severe growth retardation in rats. Am J Physiol 1985;249: G792-G799.
19. Wakabayashi Y, Yamada E, Yoshida T, Takahashi H. Arginine becomes an essential amino acid after massive resection of rat small intestine. J Biol Chem 1994;269:32, 667-32, 671.
20. Dugan ME, Knabe DA, Wu G. The induction of citrulline synthesis from glutamine in enterocytes of weaned pigs is not due primarily to age or change in diet. J Nutr 1995;125:2388-2393.
21. Jianfeng G, Weiming Z, Ning L, et al. Serum citrulline is a simple quantitative marker for small intestinal enterocyte mass and absorption function in short bowel patients. J Surg Res 2005;127:177-182.
22. Rabier D, Kamoun P. Metabolism of citrulline in man. Amino Acids 1995;9:299-316.
23. Yu YM, Burke JF, Tompkins RG, et al. Quantitative aspects of interorgan relationships among arginine and citrulline metabolism. Am J Physiol 1996;271: E1098-E1109.
24. Wu G, Knabe DA, Flynn NE. Synthesis of citrulline from glutamine in pig enterocytes. Biochem J 1994;294:115-121.
25. Wu G. Intestinal mucosal amino acid catabolism. J Nutr 1998;128:1249-1252.
26. Dillon EL, Knabe DA, Wu G. Lactate inhibits citrulline and arginine synthesis from proline in pig enterocytes. Am J Physiol 1999;276: G1079-G1086.
27. Curis E, Nicolis I, Moinard C, et al. Almost all about citrulline in mammals. Amino Acids 2005;29:177-205.
28. Curis E, Crenn P, Cynober L. Citrulline and the gut. Curr Opin Clin Nutr Metab Care 2007;10:620-626.
29. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008;27:328-339.
30. Luiking YC, Poeze M, Ramsay G, Deutz NE. Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 2009;89:142-152.
31. Sandstrom P, Trulsson L, Gasslander T, et al. Serum amino acid profile in patients with acute pancreatitis. Amino Acids 2008;35:225-231.
32. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: A preliminary report. Transplantation 2001;72:1212-1216.
33. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. Transplant Proc 2002;34:915-917.
34. Pappas PA, Tzakis AG, Gaynor JJ, et al. An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplant. Am J Transplant 2004;4:1124-1132.
35. David AI, Selvaggi G, Ruiz P, et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007;84:1077-1081.
36. David AI, Szutan LA, Gaynor J, et al. Valor crítico da citrulina para as complicações do enxerto no transplante de intestino. Rev Assoc Med Bras 2008;54:426-429.
37. Crenn P, Coudray-Lucas C, Cynober L, Messing B. Postabsorptive plasma citrulline concentration: A marker of intestinal failure in humans. Transplant Proc 1998;30:2528.
38. Crenn P, Coudray-Lucas C, Thuillier F, et al. Post-absorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-1505.
39. Crenn P, Vahedi K, Lavergne-Slove A, et al. Plasma citrulline: A marker of enterocyte mass in villous atrophyassociated small bowel disease. Gastroenterology 2003;124:1210-1219.
40. Luo M, Fernández-Estívariz C, Manatunga AK, et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome? J Parenter Enteral Nutr 2007;31:1-7.
41. Lutgens LC, Deutz NE, Gueulette J, et al. Citrulline: A physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys 2003;57:1067-1074.
42. Lutgens LC, Blijlevens NM, Deutz NE, et al. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: A comparison with sugar permeability tests. Cancer 2005;103:191-199.
43. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP. Citrulline: A potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004;34:193-196.
44. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop São Paulo 1972;14:397-400.
45. Duvall RH, DeWitt WB. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 1967;16:483-486.
46. Vassef AA. Direct micromethod for colorimetry of serum ornithine carbamoyltransferase activity with use of a linear standard curve. Clin Chem 1978;24:101-107.
47. Cheever AW, Lenzi JA, Lenzi HL, Andrade ZA. Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 2002;97:917-940.
48. Assef JC, Vieira ACPO, Saito HCGS, et al. Modelo experimental de formação de varizes esofágicas por hipertensão portal esquistossomótica em hamsters. Rev Col Bras Cir 2005;32:209-213.
49. Mesquita GV, Brandt CT, Santos SM, Maricevich JPBR. Avaliaçã o de pacientes esquistossomóticos quanto ao conteúdo mineral ósseo, nível de magnésio corporal total e atividade da enzima lecitina: Colesterol acetiltransferase em pós-esplenectomizados com auto-implante esplênico. Rev Bras Ortop 2004;39:49-58.
50. Bogliolo L. The anatomic picture of the liver in hepatoesplenic Schistosomiasis mansoni. Ann Trop Med Parasit 1957;51:1-14.
51. Magalhães Filho A, Coutinho-Abath E. Splenic reactions in Swiss albino mice to single and multiple infections with Schistosoma mansoni. Am J Trop Med Hyg 1961;10:356-364.
52. Coutinho EM, Barros AF, Barbosa A Jr, et al. Host nutritional status as a contributory factor to the remodeling of schistosomal hepatic fibrosis. Mem Inst Oswaldo Cruz 2003;98:919-925.
53. Cynober LA. Plasma amino acid levels with a note on membrane transport: Characteristics, regulation and metabolic significance. Nutrition 2002;18:761-766.
54. Stadecker MJ, Asahi H, Finger E, et al. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev 2004;201:168-179.
55. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Ver Immunol 2002;2:499-511.
56. Serufo JC, Lambertucci JR. Schistosomiasis and viral hepatitides: A review. Rev Soc Bras Med Trop 1997;30:313-322.
57. Modolell M, Corraliza IM, Link F, et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995;25:1101-1104.
58. Abath FG, Morais CN, Montenegro CE, et al. Immunopathogenic mechanisms in schistosomiasis: What can be learned from human studies? Trends Parasitol 2006;22:85-91.
59. Cicalese L, Sileri P, Green M, et al. Bacterial translocation in clinical intestinal transplantation. Transplantation 2001;71:1414-1417.
60. Mainous MR, Tso P, Berg RD, Deitch EA. Studies of the route, magnitude and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 1991;126:33-37.
61. Cucchetti A, Siniscalchi A, Bagni A, et al. Bacterial translocation in adult small bowel transplantation. Transplant Proc 2009;41:1325-1330.
62. Sileri P, Rastellini C, Dicuonzo G, et al. Transplantation of the intestines and bacterial translocation. G Chir 2000;21:196-204.
63. Ferraz EM, Bacelar TS, Ferraz AAB, et al. Infecção de ferida pós-esplenectomia com ou sem esquistossomose hepatoesplênica. Rev Col Bras Cir 1991;18:75-79.
64. Ferraz AAB, Campos JM, Araújo Júnior JG, et al. Gut bacterial translocation and postoperative infections: A prospective study in schistosomotic patients. Surg Infect 2005;6:197-201.